Home > Search Results: Tassorelli, Cristina
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 5 records in 0.02 seconds.
Articles, 5 records found
Articles 5 records found  
1.
12 p, 986.0 KB Perceived barriers to career progression in the headache field : A global web-based cross-sectional survey / de Boer, Irene (Leiden University Medical Center) ; Ambrosini, Anna (IRCCS Neuromed (Itàlia)) ; Halker Singh, Rashmi B (Mayo Clinic (Estats Units d'Amèrica)) ; Baykan, Betül (Istanbul University) ; Buse, Dawn C (DepAlbert Einstein College of Medicine) ; Tassorelli, Cristina (University of Pavia) ; Jensen, Rigmor H (University of Copenhagen) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Terwindt, Gisela M (Leiden University Medical Center) ; Universitat Autònoma de Barcelona
It is well recognized that underrepresented and minoritized groups do not have the same career opportunities. However, there are limited data on the range and specifics of potential barriers that withhold people in headache medicine and science from reaching their full potential. [...]
2022 - 10.1177/03331024221123081
Cephalalgia, Vol. 42 (september 2022) , p. 1498-1509  
Detailed record - Creative Commons
2.
10 p, 705.8 KB Migraine-attributed burden, impact and disability, and migraine-impacted quality of life : Expert consensus on definitions from a Delphi process / Steiner, Timothy J (Imperial College London) ; Terwindt, Gisela M (Leiden University Medical Center) ; Katsarava, Zaza (EVEX Medical Corporation (Georgia)) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gantenbein, Andreas R (University Hospital Zurich (Suïssa)) ; Roche, Sarah L (Eli Lilly and Company) ; Dell'Agnello, Grazia (Eli Lilly Italia SpA) ; Tassorelli, Cristina (IRCCS Mondino Foundation) ; Universitat Autònoma de Barcelona
Migraine-attributed burden, impact, disability and migraine-impacted quality of life are important concepts in clinical management, clinical and epidemiological research, and health policy, requiring clear and agreed definitions. [...]
2022 - 10.1177/03331024221110102
Cephalalgia, Vol. 42 (july 2022) , p. 1387-1396  
Detailed record - Creative Commons
3.
13 p, 575.7 KB Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey / Pozo-Rosich, Patricia (Universitat Autònoma de Barcelona) ; Gil-Gouveia, Raquel (Hospital da Luz (Lisboa, Portugal)) ; Donnet, Anne (Timone Hospital) ; Poole, Anne-Christine (Private Practice: Oslo Headache Centre) ; Gendolla, Astrid (Private Practice: Essen) ; Afridi, Shazia (Guy's and St Thomas' NHS Trust) ; Sanchez-De la Rosa, Rainel (Novartis Pharma AG) ; Terwindt, Gisela M. (Leiden University Medical Center) ; Tassorelli, Cristina (University of Pavia)
Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision to (dis)continue it are not clearly defined in clinical practice. [...]
2021 - 10.1002/ejp.1831
European Journal of Pain (Regne Unit), Vol. 25 (july 2021) , p. 2177-2189  
Detailed record - Creative Commons
4.
15 p, 678.4 KB Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache Society / Diener, Hans-Christoph (Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany) ; Ashina, Messoud (University of Copenhagen) ; Durand-Zaleski, Isabelle (Santé Publique Hôpital Henri Mondor, Créteil, France) ; Kurth, Tobias (Charité - Universitätsmedizin Berlin) ; Lantéri-Minet, Michel (Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France) ; Lipton, Richard B. (Albert Einstein College of Medicine) ; Ollendorf, Daniel A. (Value Measurement and Global Health Initiatives, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, , Boston, MA, USA) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tassorelli, Cristina (Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy) ; Terwindt, Gisela (Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands) ; Universitat Autònoma de Barcelona
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. [...]
2021 - 10.1177/0333102421989247
Cephalalgia, Vol. 41 (january 2021) , p. 279-293  
Detailed record - Creative Commons
5.
24 p, 365.1 KB Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth edition / Diener, Hans-Christoph (University Hospital Essen (Alemanya)) ; Tassorelli, Cristina (University of Pavia) ; Dodick, David W. (Mayo Clinic) ; Silberstein, Stephen D. (Thomas Jefferson University) ; Lipton, Richard B. (Albert Einstein College of Medicine) ; Ashina, Messoud (University of Copenhagen) ; Becker, Werner J. (University of Calgary) ; Ferrari, Michel D.. (Leiden University Medical Center) ; Goadsby, Peter J. (King's College London) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ; Wang, Shuu-Jiun (National Yang-Ming University) ; Mandrekar, Jay (Mayo Clinic Rochester) ; Universitat Autònoma de Barcelona
The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. [...]
2019 - 10.1177/0333102419828967
Cephalalgia, Vol. 39 (february 2019) , p. 687-710  
Detailed record - Creative Commons

See also: similar author names
1 Tassorelli, C.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with